Polyrizon Ltd. Ordinary Shares (PLRZ) Stock Analysis

Polyrizon Ltd. Ordinary Shares (PLRZ) is a publicly traded company in the HEALTHCARE sector. It trades at $14.09, carries a market capitalization of $28.85M. This page summarizes the public market data, fundamentals, and frequently asked questions for PLRZ, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Polyrizon Ltd. Ordinary Shares currently has a Bullish sentiment score of 0.27.

About Polyrizon Ltd. Ordinary Shares

Polyrizon Ltd. is a pioneering biotechnology firm headquartered in Ra'anana, Israel, dedicated to advancing medical device hydrogels specifically tailored for nasal spray applications. By harnessing its proprietary technology, Polyrizon aims to enhance drug delivery mechanisms, addressing significant unmet medical needs and transforming therapeutic approaches in nasal treatments. With a strong commitment to innovation, the company seeks to improve patient outcomes in the healthcare sector and...

GNG Research Analysis

GNG Research scores Polyrizon Ltd. Ordinary Shares (PLRZ) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PLRZ.

Frequently Asked Questions

Does PLRZ pay dividends?

Polyrizon Ltd. Ordinary Shares (PLRZ) does not currently pay a regular dividend.

What is PLRZ's market cap?

Polyrizon Ltd. Ordinary Shares (PLRZ) has a market capitalization of $28.85M with a current stock price of $14.09.